Literature DB >> 3076113

Risk factors for coronary heart disease. Selected recent epidemiological advances.

S B Hulley1.   

Abstract

Several recent advances in our understanding of the epidemiology and prevention of coronary artery disease are presented, highlighting the current status of the 3 major risk factors: blood cholesterol, blood pressure and cigarette smoking. There is a striking analogy between serum cholesterol and diastolic blood pressure in the pattern of the association with coronary heart disease (CHD). Mortality follow-up of the 361,662 middle-aged men screened for the Multiple Risk Factor Intervention Trial (MRFIT) shows that each of these risk factors identifies a large group of patients (the top 15% of the population distribution) who have a 4-fold higher risk of CHD death than those in the bottom 15%, and that each has a continuously rising gradient of risk for people with intermediary levels. The implication from these findings, and from the clinical trial data, is that public health and clinical policies directed at blood cholesterol should be made similar to those that have become widespread for blood pressure in the past 2 decades; i.e. measuring the level periodically in all adults and intervening to prevent CHD in those at highest risk. The public health campaign to reduce cigarette smoking has been bolstered by new evidence on the hazards of ambient smoke. One example comes from the clinical trial cohort of the MRFIT, in which non-smoking men who were married to smoking wives had nearly twice the all-cause mortality rate of non-smoking men who were married to non-smoking wives.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3076113     DOI: 10.2165/00003495-198800363-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  10 in total

1.  Clofibrate and niacin in coronary heart disease.

Authors: 
Journal:  JAMA       Date:  1975-01-27       Impact factor: 56.272

2.  Change in public perspective on cholesterol and heart disease. Results from two national surveys.

Authors:  B Schucker; K Bailey; J T Heimbach; M E Mattson; J T Wittes; C M Haines; D J Gordon; J A Cutler; V S Keating; R S Goor
Journal:  JAMA       Date:  1987-12-25       Impact factor: 56.272

3.  The San Francisco experience with regulation of smoking in the workplace: the first twelve months.

Authors:  M J Martin; M F Silverman
Journal:  Am J Public Health       Date:  1986-05       Impact factor: 9.308

4.  Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

Authors:  M J Martin; S B Hulley; W S Browner; L H Kuller; D Wentworth
Journal:  Lancet       Date:  1986-10-25       Impact factor: 79.321

5.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Authors:  M H Frick; O Elo; K Haapa; O P Heinonen; P Heinsalmi; P Helo; J K Huttunen; P Kaitaniemi; P Koskinen; V Manninen
Journal:  N Engl J Med       Date:  1987-11-12       Impact factor: 91.245

6.  Health policy for treating hyperlipidemia: analogy with hypertension and prospects for the next decade.

Authors:  S B Hulley; M J Martin
Journal:  Am J Cardiol       Date:  1986-06-27       Impact factor: 2.778

7.  Change in physician perspective on cholesterol and heart disease. Results from two national surveys.

Authors:  B Schucker; J T Wittes; J A Cutler; K Bailey; D R Mackintosh; D J Gordon; C M Haines; M E Mattson; R S Goor; B M Rifkind
Journal:  JAMA       Date:  1987-12-25       Impact factor: 56.272

8.  Effects of passive smoking in the Multiple Risk Factor Intervention Trial.

Authors:  K H Svendsen; L H Kuller; M J Martin; J K Ockene
Journal:  Am J Epidemiol       Date:  1987-11       Impact factor: 4.897

Review 9.  Risk factor modification after myocardial infarction.

Authors:  D Siegel; D Grady; W S Browner; S B Hulley
Journal:  Ann Intern Med       Date:  1988-08-01       Impact factor: 25.391

Review 10.  Effect of risk status on treatment criteria. Implications of hypertension trials.

Authors:  W S Browner; S B Hulley
Journal:  Hypertension       Date:  1989-05       Impact factor: 10.190

  10 in total
  1 in total

1.  Population attributable fractions for Type 2 diabetes: an examination of multiple risk factors including symptoms of depression and anxiety.

Authors:  Kiyuri Naicker; Douglas Manuel; Simon Øverland; Jens C Skogen; Jeffrey A Johnson; Børge Sivertsen; Ian Colman
Journal:  Diabetol Metab Syndr       Date:  2018-11-22       Impact factor: 3.320

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.